6 June 2019 in News

How to generate high-quality, alignable sequence data?

Innovation Alert: Mid-read sequencing Sequencing of PE250 reads on the NovaSeq 6000   Printing a book of more than 2 billion pages, every two days. Illumina’s NovaSeq 6000 has made…

Read More
4 June 2019 in News

GenomeScan to offer two Bioinformatics PhD traineeships as part of the EU Horizon 2020 program

Two EU-funded Consortium Grants for PhD training at GenomeScan GenomeScan has been granted two Marie Skłodowska-Curie Actions within the Innovative Training Network calls of the European Union-funded Horizon 2020 Program….

Read More
29 May 2019 in Blog

Some highlights from SMRT Meeting, Leiden, May 2019

Some highlights from SMRT Leiden 2019 Innovation in long-read sequencing applications SMRT Leiden – 7th -9th of May 2019 Arnoud Schmitz – PacBio® expert at GenomeScan The yearly PacBio meeting…

Read More
23 May 2019 in Science article

Widespread and Functional RNA Circularizationin Localized Prostate Cancer.

Widespread and Functional RNA Circularizationin Localized Prostate Cancer Sujun Chen, Vincent Huang, Xin Xu, Julie Livingstone, Fraser Soares, Jouhyun Jeon, Yong Zeng, Junjie Tony Hua, Jessica Petricca, Haiyang Guo, Miranda…

Read More

Competitive, fast, and adaptable RNA Sequencing services

By | News | No Comments

RNA sequencing is an affordable and dependable tool driving R&D and clinical projects. To answer scientific challenges, GenomeScan develops innovative methods to analyze RNA samples. Minute populations of sorted cells or FFPE samples are no longer hampering progression of your project. Get direct access to a wide range of RNA-seq services under ISO/IEC 17015 accreditation. Our experienced scientific team can determine with you the optimal solution to reach your objectives. Tell us more about your project to get started.

Recently, we co-authored a study involving RNASeq published in a high-impact journal. Read the full article in Cell.

You can review our RNASeq service portfolio on the website.

07.04.2019 RNAseq for all sample types 1 Blog

Widespread RNA circularization events define clinically distinct tumor subtypes

By | Science article | No Comments

This article describes the results of a multidisciplinary prostate cancer study. Prof. dr. ir. Guido Jenster and his collaborators (NGS ProToCol consortium) showed that clinical roles of circular RNA’s are different from their linear counterparts, promoting cell proliferation in localized prostate cancer. GenomeScan contributed to the RNA sequencing and data processing.

Read full article: https://www.sciencedirect.com/science/article/pii/S0092867419300583

Prostate cancer article Blog